0000950170-23-045862.txt : 20230831
0000950170-23-045862.hdr.sgml : 20230831
20230831182216
ACCESSION NUMBER: 0000950170-23-045862
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230831
FILED AS OF DATE: 20230831
DATE AS OF CHANGE: 20230831
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gruia Gabriela
CENTRAL INDEX KEY: 0001860326
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32979
FILM NUMBER: 231230197
MAIL ADDRESS:
STREET 1: C/O TSCAN THERAPEUTICS, INC.
STREET 2: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Molecular Templates, Inc.
CENTRAL INDEX KEY: 0001183765
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943409596
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9301 AMBERGLEN BLVD
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78729
BUSINESS PHONE: 512 896 1555
MAIL ADDRESS:
STREET 1: 9301 AMBERGLEN BLVD
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78729
FORMER COMPANY:
FORMER CONFORMED NAME: THRESHOLD PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20020828
4
1
ownership.xml
4
X0508
4
2023-08-31
0001183765
Molecular Templates, Inc.
MTEM
0001860326
Gruia Gabriela
C/O MOLECULAR TEMPLATES, INC.
9301 AMBERGLEN BLVD., SUITE 100
AUSTIN
TX
78729
true
true
false
false
Interim Chief Medical Officer
false
Stock Option (right to buy)
8.51
2023-08-31
4
A
false
11666
0
A
2033-08-31
Common Stock
11666
11666
D
The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on August 11, 2023.
25% of the total number of shares subject to the option shall vest on August 31, 2024 and the remaining 75% shall vest in thirty-six (36) equal monthly installments, subject to the reporting person's continued service through the applicable vesting dates.
/s/ Gabriela Gruia
2023-08-31